Cargando…
Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness
BACKGROUND AND OBJECTIVES: The calculated panel reactive of antibodies (cPRAs) necessary for kidney donor-pair exchange and highly sensitized programs are estimated using different panel reactive antibody (PRA) calculators based on big enough samples in Eurotransplant (EUTR), United Network for Orga...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425465/ https://www.ncbi.nlm.nih.gov/pubmed/28553286 http://dx.doi.org/10.3389/fimmu.2017.00540 |
_version_ | 1783235305247080448 |
---|---|
author | Asensio, Esther López-Hoyos, Marcos Romón, Íñigo Ontañón, Jesús San Segundo, David |
author_facet | Asensio, Esther López-Hoyos, Marcos Romón, Íñigo Ontañón, Jesús San Segundo, David |
author_sort | Asensio, Esther |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: The calculated panel reactive of antibodies (cPRAs) necessary for kidney donor-pair exchange and highly sensitized programs are estimated using different panel reactive antibody (PRA) calculators based on big enough samples in Eurotransplant (EUTR), United Network for Organ Sharing (UNOS), and Canadian Transplant Registry (CTR) websites. However, those calculators can vary depending on the ethnic they are applied. Here, we develop a PRA calculator used in the Spanish Program of Transplant Access for Highly Sensitized patients (PATHI) and validate it with EUTR, UNOS, and CTR calculators. METHODS: The anti-human leukocyte antigen (HLA) antibody profile of 42 sensitized patients on waiting list was defined, and cPRA was calculated with different PRA calculators. RESULTS: Despite different allelic frequencies derived from population differences in donor panel from each calculator, no differences in cPRA between the four calculators were observed. The PATHI calculator includes anti-DQA1 antibody profiles in cPRA calculation; however, no improvement in total cPRA calculation of highly sensitized patients was demonstrated. INTERPRETATION AND CONCLUSION: The PATHI calculator provides cPRA results comparable with those from EUTR, UNOS, and CTR calculators and serves as a tool to develop valid calculators in geographical and ethnic areas different from Europe, USA, and Canada. |
format | Online Article Text |
id | pubmed-5425465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54254652017-05-26 Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness Asensio, Esther López-Hoyos, Marcos Romón, Íñigo Ontañón, Jesús San Segundo, David Front Immunol Immunology BACKGROUND AND OBJECTIVES: The calculated panel reactive of antibodies (cPRAs) necessary for kidney donor-pair exchange and highly sensitized programs are estimated using different panel reactive antibody (PRA) calculators based on big enough samples in Eurotransplant (EUTR), United Network for Organ Sharing (UNOS), and Canadian Transplant Registry (CTR) websites. However, those calculators can vary depending on the ethnic they are applied. Here, we develop a PRA calculator used in the Spanish Program of Transplant Access for Highly Sensitized patients (PATHI) and validate it with EUTR, UNOS, and CTR calculators. METHODS: The anti-human leukocyte antigen (HLA) antibody profile of 42 sensitized patients on waiting list was defined, and cPRA was calculated with different PRA calculators. RESULTS: Despite different allelic frequencies derived from population differences in donor panel from each calculator, no differences in cPRA between the four calculators were observed. The PATHI calculator includes anti-DQA1 antibody profiles in cPRA calculation; however, no improvement in total cPRA calculation of highly sensitized patients was demonstrated. INTERPRETATION AND CONCLUSION: The PATHI calculator provides cPRA results comparable with those from EUTR, UNOS, and CTR calculators and serves as a tool to develop valid calculators in geographical and ethnic areas different from Europe, USA, and Canada. Frontiers Media S.A. 2017-05-11 /pmc/articles/PMC5425465/ /pubmed/28553286 http://dx.doi.org/10.3389/fimmu.2017.00540 Text en Copyright © 2017 Asensio, López-Hoyos, Romón, Ontañón and San Segundo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Asensio, Esther López-Hoyos, Marcos Romón, Íñigo Ontañón, Jesús San Segundo, David Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness |
title | Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness |
title_full | Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness |
title_fullStr | Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness |
title_full_unstemmed | Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness |
title_short | Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness |
title_sort | assessment of spanish panel reactive antibody calculator and potential usefulness |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425465/ https://www.ncbi.nlm.nih.gov/pubmed/28553286 http://dx.doi.org/10.3389/fimmu.2017.00540 |
work_keys_str_mv | AT asensioesther assessmentofspanishpanelreactiveantibodycalculatorandpotentialusefulness AT lopezhoyosmarcos assessmentofspanishpanelreactiveantibodycalculatorandpotentialusefulness AT romoninigo assessmentofspanishpanelreactiveantibodycalculatorandpotentialusefulness AT ontanonjesus assessmentofspanishpanelreactiveantibodycalculatorandpotentialusefulness AT sansegundodavid assessmentofspanishpanelreactiveantibodycalculatorandpotentialusefulness |